The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f
3 min read IF ANYONE CAN MAKE RATTAN hot, it’s Alexander Skarsgård. The actor’s latest film project, about a craftsman who creates a wicker husband (Skarsgård) for a lonely woman (played by Olivia Colman), has been an unlikely hit since its release in theaters last week. But basket weave isn’t the only material Skarsgård’s rocking—he’s
PAGE, Ariz. — Doug Herrera still lives in the house his father built, though his dad died some time ago from cancer. Herrera wonders if that illness could have been linked to pollutants from nearby uranium mining. Now, he worries that a possible new neighbor — a proposed $10 billion mega data center — could
Press release from the Humboldt County Joint Information Center:
Humboldt County’s count of confirmed COVID-19 cases rose to 195, after six additional cases were reported today.
Today’s alert level stands at a two and has remained unchanged since the tool was launched Thursday. This is due, in part, to a high demand for testing and testing supplies nationwide, according to Humboldt County Health Officer Dr. Teresa Frankovich.
Dr. Frankovich said that even with an increased demand on testing and the slower turnaround time right now, screening for the virus is still a useful public health tool. “Some of our more recent cases have been individuals tested through commercial laboratories collected either at the OptumServe site in Eureka or their provider’s office, so we want to encourage people who are not experiencing symptoms to sign up for a test at Optum,” she said. “Individuals with symptoms, such as fever, cough or shortness of breath, should reach out to their primary care provider or to the Joint Information Center if they do not have a provider so they can be tested. Ill individuals should seek emergency care if symptoms become severe.”
Visit LHI.care/covidtesting or call 888-634-1123 to make an appointment at the OptumServe site at Redwood Acres in Eureka. Please note only available appointments will be shown on the website. If no time slots are available, check back to schedule.
Humboldt County COVID-19 Data Dashboard: humboldtgov.org/dashboard, Follow us on Facebook: @HumCoCOVID19, Instagram: @HumCoCOVID19, Twitter: @HumCoCOVID19, and Humboldt Health Alert: humboldtgov.org/HumboldtHealthAlert
###
=historic data. All data from the Humboldt County Joint Information Center.
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f